Effect of zoledronic acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: Results from horizon-PFT

被引：0
|
作者：
Cauley, Jane A.
Black, Dennis
Boonen, Steven R.
Cummings, Steven
Delmas, Pierre
Eastell, Richard
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Leuven Univ, Ctr Metab Bone Dis, Div Geriatr Med, Louvain, Belgium
[4] Univ Lyon 1, F-69365 Lyon, France
[5] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England
来源：
OSTEOPOROSIS INTERNATIONAL | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [31] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis
    Black, Dennis
    Delmas, Pierre
    Eastell, Richard
    Reid, Ian
    Boonen, Steven R.
    Cauley, Jane A.
    Lakatos, Peter
    Leung, Ping C.
    Man, Zulema
    Eriksen, Erik F.
    Mesenbrink, Peter
    Hue, Trisha
    Cummings, Steven
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S222 - S223
  • [32] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis
    Black, D.
    Detmas, P. D.
    Eastell, R.
    Reid, I.
    Boonen, S.
    Cauley, J. A.
    Lakatos, P.
    Leung, P. C.
    Man, Z.
    Eriksen, E. F.
    Mesenbrink, P.
    Hue, T.
    Langdahl, B.
    Cummings, S.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S45 - S46
  • [33] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis
    Black, D.
    Delmas, P. D.
    Eastell, R.
    Reid, I.
    Boonen, S. R.
    Boonens, S. R.
    Cauley, J. A.
    Cosman, F.
    Lakatoss, P.
    Leung, P. C.
    Man, Z.
    Eriksen, E. F.
    Mesenbrink, P.
    Cummings, T. H. S.
    [J]. BONE, 2007, 40 (06) : S158 - S158
  • [34] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis
    Eastell, R.
    Black, D. M.
    Cauley, J. A.
    Cosman, F.
    Cummings, S. R.
    Delmas, P. D.
    Eriksen, E. F.
    Fraser, W. D.
    Hue, T.
    Lakatos, P.
    Leung, P. C.
    Man, Z.
    McLellan, A. R.
    Mesenbrink, P.
    Reid, D. M.
    Reid, I. R.
    Boonen, S. R.
    [J]. RHEUMATOLOGY, 2007, 46 : I4 - I4
  • [35] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis
    Cauley, Jane A.
    Black, Dennis M.
    Levine, Bruce J.
    Eriksen, Erik F.
    Hu, Huilin
    Cummings, Steven R.
    [J]. OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 112S - 113S
  • [36] The impact of background OP meds on baseline fracture risk from the horizon PFT with zoledronic acid
    Zhang, J
    Delmas, PD
    Eastell, R
    Reid, IR
    Rosario-Jansen, T
    Flood, M
    Tong, K
    Caminis, J
    Black, DM
    [J]. BONE, 2005, 36 : S424 - S424
  • [37] AFTER 3 YEARS OF ANNUAL ZOLEDRONIC ACID, WHO SHOULD REMAIN ON TREATMENT? RESULTS FROM THE HORIZON-PFT EXTENSION STUDY
    Eastell, Richard
    Cosman, Felicia
    Cauley, Jane A.
    Boonen, Steven
    Palermo, Lisa
    Reid, Ian R.
    Cummings, Steven R.
    Black, Dennis M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S240 - S241
  • [38] Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis
    Delmas, Pierre D.
    Munoz, Francoise
    Black, Dennis M.
    Cosman, Felicia
    Boonen, Steven
    Watts, Nelson B.
    Kendler, David
    Eriksen, Erik F.
    Mesenbrink, Peter G.
    Eastell, Richard
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (09) : 1544 - 1551
  • [39] The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT)
    Black, Dennis
    Reid, Ian
    Cauley, Jane
    Boonen, Steven
    Cosman, Felicia
    Leung, Ping
    Lakatos, Peter
    Man, Zulema
    Cummings, Steven
    Hue, Trisha
    Su, Guoqin
    Bucci-Rechtweg, Christina
    Tan, Monique
    Aftring, Paul
    Eastell, Richard
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [40] The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
    Black, Dennis M.
    Reid, Ian R.
    Boonen, Steven
    Bucci-Rechtweg, Christina
    Cauley, Jane A.
    Cosman, Felicia
    Cummings, Steven R.
    Hue, Trisha F.
    Lippuner, Kurt
    Lakatos, Peter
    Leung, Ping Chung
    Man, Zulema
    Martinez, Ruvie Lou Maria
    Tan, Monique
    Ruzycky, Mary Ellen
    Su, Guoqin
    Eastell, Richard
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (02) : 243 - 254
12345